Mechanisms and consequences of oxidative damage to extracellular matrix

Biochemical Society Transactions

Volumn 39, Issue 5, 2011, Pages 1279-1287

  Kennett, Eleanor C ^a   Chuang, Christine Y ^a,b   Degendorfer, Georg ^a   Whitelock, John M ^b   Davies, Michael J ^a,c  

^a HEART RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c University of Sydney   (Australia)

Author keywords

Extracellular matrix (ECM); Glycosaminoglycan (GAG); Metal ion; Myeloperoxidase (MPO); Oxidative stress; Peroxynitrite

Indexed keywords

3 NITROTYROSINE; ADVANCED GLYCATION END PRODUCT; ARGININE; COLLAGEN TYPE 5; EOSINOPHIL PEROXIDASE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; HISTIDINE; INDUCIBLE NITRIC OXIDE SYNTHASE; LYSINE; METHIONINE; MYELOPEROXIDASE; NERVE CELL ADHESION MOLECULE; NITRIC OXIDE; OXIDIZING AGENT; PERLECAN; PEROXYNITRITE; PORPHYRIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR 4; TOSYLCHLORAMIDE SODIUM; TRYPTOPHAN; TYROSINE;

AIR POLLUTANT; ASTHMA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CATABOLISM; CELL ADHESION; CELL DAMAGE; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; CHELATION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ENDOTHELIUM CELL; ENZYME BINDING; EOSINOPHIL; EXTRACELLULAR MATRIX; GLUCOSE BLOOD LEVEL; GLYCATION; HYDROGEN BOND; HYDROPHILICITY; HYDROPHOBICITY; IN VIVO STUDY; INFLAMMATORY DISEASE; LEUKOCYTE; MACROPHAGE; MONOCYTE; NEUTROPHIL; OXIDATION; OXIDATIVE STRESS; PH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN UNFOLDING; RADIATION EXPOSURE; REVIEW; TRYPTOPHAN METABOLISM; ULTRAVIOLET RADIATION; VASCULAR SMOOTH MUSCLE;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 80053360919     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0391279     Document Type: Review

References (78)

1. Comper, W.D. (1996) Extracellular Matrix, Harwood Academic Publishers, Amsterdam.
2. Iozzo, R.V. (2005) Basement membrane proteoglycans: from cellar to ceiling. Nat. Rev. Mol. Cell Biol. 6, 646-656
3. Rees, M.D., Kennett, E.C., Whitelock, J.M. and Davies, M.J. (2008) Oxidative damage to extracellular matrix and its role in human pathologies. Free Radical Biol. Med. 44, 1973-2001
4. Whitelock, J.M., Murdoch, A.D., Iozzo, R.V. and Underwood, P.A. (1996) The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J. Biol. Chem. 271, 10079-10086 (Pubitemid 26131567)
5. Whitelock, J.M. and Iozzo, R.V. (2005) Heparan sulfate: a complex polymer charged with biological activity. Chem. Rev. 105, 2745-2764 (Pubitemid 41055329)
6. Fu, X., Kassim, S.Y., Parks, W.C. and Heinecke, J.W. (2001) Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7): a mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J. Biol. Chem. 276, 41279-41287
7. Wang, Y., Rosen, H., Madtes, D.K., Shao, B., Martin, T.R., Heinecke, J.W. and Fu, X. (2007) Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue: an oxidative mechanism for regulating proteolysis during inflammation. J. Biol. Chem. 282, 31826-31834 (Pubitemid 350106428)
8. Babior, B.M. (1987) The respiratory burst oxidase. Trends Biochem. Sci. 12, 241-243
9. Davies, M.J., Hawkins, C.L., Pattison, D.I. and Rees, M.D. (2008) Mammalian heme peroxidases: from molecular mechanisms to health implications. Antioxid. Redox Signal. 10, 1199-1234 (Pubitemid 351634397)
10. van der Veen, B.S., De Winther, M.P. and Heeringa, P. (2009) Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid. Redox Signal. 11, 2899-2937
11. Davies, M.J. (2011) Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention. J. Clin. Biochem. Nutr. 48, 8-19
12. Thomas, E.L., Grisham, M.B. and Jefferson, M.M. (1986) Cytotoxicity of chloramines. Methods Enzymol. 132, 585-593
13. Rees, M.D. and Davies, M.J. (2006) Heparan sulfate degradation via reductive homolysis of its N-chloro derivatives. J. Am. Chem. Soc. 128, 3085-3097
14. Hawkins, C.L. and Davies, M.J. (1998) Hypochlorite-induced damage to proteins: formation of nitrogen-centred radicals from lysine residues and their role in protein fragmentation. Biochem. J. 332, 617-625 (Pubitemid 28306685)
15. Hawkins, C.L. and Davies, M.J. (1999) Hypochlorite-induced oxidation of proteins in plasma: formation of chloramines and nitrogen-centred radicals and their role in protein fragmentation. Biochem. J. 340, 539-548 (Pubitemid 29286577)
16. Ignarro, L.J. (1999) Nitric oxide: a unique endogenous signaling molecule in vascular biology. Biosci. Rep. 19, 51-71
17. Radi, R., Peluffo, G., Alvarez, M.N., Naviliat, M. and Cayota, A. (2001) Unraveling peroxynitrite formation in biological systems. Free Radical Biol. Med. 30, 463-488 (Pubitemid 32162954)
18. Halliwell, B. and Gutteridge, J.M.C. (1999) Free Radicals in Biology and Medicine. Oxford University Press, Oxford
19. Stadler, N., Lindner, R.A. and Davies, M.J. (2004) Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler. Thromb. Vasc. Biol. 24, 949-954 (Pubitemid 38620877)
20. Davies, M.J., Fu, S. and Dean, R.T. (1995) Protein hydroperoxides can give rise to reactive free radicals. Biochem. J. 305, 643-649
21. Verzijl, N., DeGroot, J., Oldehinkel, E., Bank, R.A., Thorpe, S.R., Baynes, J.W., Bayliss, M.T., Bijlsma, J.W., Lafeber, F.P. and Tekoppele, J.M. (2000) Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem. J. 350, 381-387
22. Lesley, J., Hascall, V.C., Tammi, M. and Hyman, R. (2000) Hyaluronan binding by cell surface CD44. J. Biol. Chem. 275, 26967-26975
23. Davies, M.J. and Gilbert, B.C. (1991) Free radical reactions: fragmentation and rearrangements in aqueous solution. Adv. Detailed React. Mech. 1, 35-81
24. Von Sonntag, C. (1980) Free radical reactions of carbohydrates as studied by radiation techniques. Adv. Carbohydr. Chem. 37, 7-77
25. Kennett, E.C. and Davies, M.J. (2007) Degradation of matrix glycosaminoglycans by peroxynitrite/peroxynitrous acid: evidence for a hydroxyl-radical-like mechanism. Free Radical Biol. Med. 42, 1278-1289 (Pubitemid 46428518)
26. Kennett, E.C. and Davies, M.J. (2009) Glycosaminoglycans are fragmented by hydroxyl, carbonate, and nitrogen dioxide radicals in a site-selective manner: implications for peroxynitrite-mediated damage at sites of inflammation. Free Radical Biol. Med. 47, 389-400
27. Rees, M.D., Hawkins, C.L. and Davies, M.J. (2003) Hypochlorite-mediated fragmentation of hyaluronan, chondroitin sulfates, and related N-acetyl glycosamines: evidence for chloramide intermediates, free radical transfer reactions, and site-specific fragmentation. J. Am. Chem. Soc. 125, 13719-13733 (Pubitemid 37386047)
28. Al-Assaf, S., Navaratnam, S., Parsons, B.J. and Phillips, G.O. (2003) Chain scission of hyaluronan by peroxynitrite. Arch. Biochem. Biophys. 411, 73-82 (Pubitemid 36268781)
29. Al-Assaf, S., Navaratnam, S., Parsons, B.J. and Phillips, G.O. (2006) Chain scission of hyaluronan by carbonate and dichloride radical anions: potential reactive species in inflammation? Free Radical Biol. Med. 40, 2018-2027 (Pubitemid 43744435)
30. Hawkins, C.L. and Davies, M.J. (2001) Generation and propagation of radical reactions on proteins. Biochim. Biophys. Acta 1504, 196-219 (Pubitemid 32201893)
31. Davies, M.J. (2005) The oxidative environment and protein damage. Biochim. Biophys. Acta 1703, 93-109
32. Pattison, D.I. and Davies, M.J. (2001) Absolute rate constants for the reaction of hypochlorous acid with protein side-chains and peptide bonds. Chem. Res. Toxicol. 14, 1453-1464 (Pubitemid 32983270)
33. Pattison, D.I. and Davies, M.J. (2006) Reactions of myeloperoxidase- derived oxidants with biological substrates: gaining chemical insight into human inflammatory diseases. Curr. Med. Chem. 13, 3271-3290 (Pubitemid 44669775)
34. Alvarez, B. and Radi, R. (2003) Peroxynitrite reactivity with amino acids and proteins. Amino Acids 25, 295-311 (Pubitemid 38041267)
35. Winterbourn, C.C. and Kettle, A.J. (2000) Biomarkers of myeloperoxidase-derived hypochlorous acid. Free Radical Biol. Med. 29, 403-409
36. Herold, S. and Fago, A. (2005) Reactions of peroxynitrite with globin proteins and their possible physiological role. Comp. Biochem. Physiol. A 142, 124-129 (Pubitemid 41443571)
37. Knox, S., Fosang, A.J., Last, K., Melrose, J. and Whitelock, J. (2005) Perlecan from human epithelial cells is a hybrid heparan/chondroitin/keratan sulfate proteoglycan. FEBS Lett. 579, 5019-5023 (Pubitemid 41242846)
38. Murdoch, A.D., Dodge, G.R., Cohen, I., Tuan, R.S. and Iozzo, R.V. (1992) Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan): a chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J. Biol. Chem. 267, 8544-8557
39. Kennett, E.C., Rees, M.D., Malle, E., Hammer, A., Whitelock, J.M. and Davies, M.J. (2010) Peroxynitrite modifies the structure and function of the extracellular matrix proteoglycan perlecan by reaction with both the protein core and the heparan sulfate chains. Free Radical Biol. Med. 49, 282-293
40. Kennett, E.C. and Davies, M.J. (2008) Degradation of extracellular matrix by peroxynitrite/peroxynitrous acid. Free Radical Biol. Med. 45, 716-725
41. Whitelock, J.M., Graham, L.D., Melrose, J., Murdoch, A.D., Iozzo, R.V. and Underwood, P.A. (1999) Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells. Matrix Biol. 18, 163-178 (Pubitemid 29229702)
42. Saksela, O., Moscatelli, D., Sommer, A. and Rifkin, D.B. (1988) Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol. 107, 743-751
43. Knox, S., Merry, C., Stringer, S., Melrose, J. and Whitelock, J. (2002) Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors. J. Biol. Chem. 277, 14657-14665 (Pubitemid 34952534)
44. Koenig, W. and Khuseyinova, N. (2007) Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler. Thromb. Vasc. Biol. 27, 15-26 (Pubitemid 46360377)
45. Malmstrom, J., Larsen, K., Hansson, L., Lofdahl, C.G., Norregard-Jensen, O., Marko-Varga, G. and Westergren-Thorsson, G. (2002) Proteoglycan and proteome profiling of central human pulmonary fibrotic tissue utilizing miniaturized sample preparation: a feasibility study. Proteomics 2, 394-404 (Pubitemid 34429357)
46. Rees, M.D., Whitelock, J.M., Malle, E., Chuang, C.Y., Iozzo, R.V., Nilasaroya, A. and Davies, M.J. (2010) Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan. Matrix Biol. 29, 63-73
47. Weiss, S.J., Curnutte, J.T. and Regiani, S. (1986) Neutrophil-mediated solubilization of the subendothelial matrix: oxidative and nonoxidative mechanisms of proteolysis used by normal and chronic granulomatous disease phagocytes. J. Immunol. 136, 636-641 (Pubitemid 16208151)
48. Woods, A.A. and Davies, M.J. (2003) Evidence for HOCl-mediated oxidation of extracellular matrix proteins in human atherosclerotic plaques. Clin. Exp. Pharmacol. 30, A16
49. Woods, A.A., Linton, S.M. and Davies, M.J. (2003) Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques. Biochem. J. 370, 729-735 (Pubitemid 36315162)
50. Grone, H.J., Grone, E.F. and Malle, E. (2002) Immunohistochemical detection of hypochlorite-modified proteins in glomeruli of human membranous glomerulonephritis. Lab. Invest. 82, 5-14 (Pubitemid 34072641)
51. Vissers, M.C.M. and Thomas, C. (1997) Hypochlorous acid disrupts the adhesive properties of subendothelial matrix. Free Radical Biol. Med. 23, 401-411 (Pubitemid 27276776)
52. Laurent, T.C., Laurent, U.B. and Fraser, J.R. (1995) Functions of hyaluronan. Annu. Rev. Biochem. 54, 429-432
53. Horton, M.R., Boodoo, S. and Powell, J.D. (2002) NF-κB activation mediates the cross-talk between extracellular matrix and interferon-γ(IFN- ã) leading to enhanced monokine induced by IFN-γ (MIG) expression in macrophages. J. Biol. Chem. 277, 43757-43762 (Pubitemid 36157794)
54. Takahashi, Y., Li, L., Kamiryo, M., Asteriou, T., Moustakas, A., Yamashita, H. and Heldin, P. (2005) Hyaluronan fragments induce endothelial cell differentiation in a CD44- and CXCL1/GRO1-dependent manner. J. Biol. Chem. 280, 24195-24204 (Pubitemid 40884909)
55. Taylor, K.R., Trowbridge, J.M., Rudisill, J.A., Termeer, C.C., Simon, J.C. and Gallo, R.L. (2004) Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem. 279, 17079-17084 (Pubitemid 38560463)
56. Ibrahim, S. and Ramamurthi, A. (2008) Hyaluronic acid cues for functional endothelialization of vascular constructs. J. Tissue Eng. Regen. Med. 2, 22-32
57. Cuff, C.A., Kothapalli, D., Azonobi, I., Chun, S., Zhang, Y., Belkin, R., Yeh, C., Secreto, A., Assoian, R.K., Rader, D.J. and Pure, E. (2001) The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J. Clin. Invest. 108, 1031-1040 (Pubitemid 32946077)
58. Kramsch, D.M., Franzblau, C. and Hollander, W. (1974) Components of the protein-lipid complex of arterial elastin: their role in the retention of lipid in atherosclerotic lesions. Adv. Exp. Med. Biol. 43, 193-210
59. McKee, C.M., Lowenstein, C.J., Horton, M.R., Wu, J., Bao, C., Chin, B.Y., Choi, A.M.K. and Noble, P.W. (1997) Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor κB-dependent mechanism. J. Biol. Chem. 272, 8013-8018 (Pubitemid 27137366)
60. Evanko, S.P., Raines, E.W., Ross, R., Gold, L.I. and Wight, T.N. (1998) Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-β. Am. J. Pathol. 152, 533-546 (Pubitemid 28106400)
61. Wight, T.N. and Merrilees, M.J. (2004) Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ. Res. 94, 1158-1167 (Pubitemid 38656402)
62. Stocker, R. and Keaney, Jr, J.F. (2004) Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84, 1381-1478 (Pubitemid 39302636)
63. Theocharis, A.D., Tsolakis, I., Tsegenidis, T. and Karamanos, N.K. (1999) Human abdominal aortic aneurysm is closely related with compositional and specific structural modifications at the glycosaminoglycan level. Atherosclerosis 145, 359-368 (Pubitemid 29359145)
64. Landmesser, U., Spiekermann, S., Dikalov, S., Tatge, H., Wilke, R., Kohler, C., Harrison, D.G., Hornig, B. and Drexler, H. (2002) Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 106, 3073-3078 (Pubitemid 35440291)
65. Daugherty, A., Dunn, J., Rateri, D. and Heinecke, J. (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94, 437-444 (Pubitemid 24218123)
66. Eiserich, J.P., Baldus, S., Brennan, M.-L., Ma, W., Zhang, C., Tousson, A., Castro, L., Lusis, A.J., Nauseef, W.M., White, C.R. and Freeman, B.A. (2002) Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296, 2391-2394 (Pubitemid 34734213)
67. Baldus, S., Eiserich, J.P., Brennan, M.L., Jackson, R.M., Alexander, C.B. and Freeman, B.A. (2002) Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases. Free Radical Biol. Med. 33, 1010-1019 (Pubitemid 35284038)
68. Hazen, S.L. and Heinecke, J.W. (1997) 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99, 2075-2081 (Pubitemid 27203762)
69. 2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur. J. Biochem. 267, 4495-4503
70. Takeshita, J., Byun, J., Nhan, T.Q., Pritchard, D.K., Pennathur, S., Schwartz, S.M., Chait, A. and Heinecke, J.W. (2005) Myeloperoxidase generates 5-chlorouracil in human atherosclerotics tissue: a potential pathway for somatic mutagenesis by macrophages. J. Biol. Chem. 281, 3096-3104 (Pubitemid 43845919)
71. Beckman, J.S., Ye, Y.Z., Anderson, P.G., Chen, J., Accavitti, M.A., Tarpey, M.M. and White, C.R. (1994) Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. 375, 81-88
72. Pennathur, S., Bergt, C., Shao, B., Byun, J., Kassim, S.Y., Singh, P., Green, P.S., McDonald, T.O., Brunzell, J., Chait, A. et al. (2004) Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species. J. Biol. Chem. 279, 42977-42983 (Pubitemid 39372190)
73. Leeuwenburgh, C., Hardy, M.M., Hazen, S.L., Wagner, P., Oh-ishi, S., Steinbrecher, U.P. and Heinecke, J.W. (1997) Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272, 1433-1436 (Pubitemid 27043215)
74. Vadseth, C., Souza, J.M., Thomson, L., Seagraves, A., Nagaswami, C., Scheiner, T., Torbet, J., Vilaire, G., Bennett, J.S., Murciano, J.C. et al. (2004) Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species. J. Biol. Chem. 279, 8820-8826 (Pubitemid 38295940)
75. Fu, S., Davies, M.J., Stocker, R. and Dean, R.T. (1998) Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem. J. 333, 519-525 (Pubitemid 28398516)
76. Stanley, N., Stadler, N., Woods, A.A., Bannon, P.G. and Davies, M.J. (2006) Concentrations of iron correlate with the extent of protein, but not lipid, oxidation in advanced human atherosclerotic lesions. Free Radical Biol. Med. 40, 1636-1643
77. Kurzelewski, M., Czarnowska, E. and Beresewicz, A. (2005) Superoxideand nitric oxide-derived species mediate endothelial dysfunction, endothelial glycocalyx disruption, and enhanced neutrophil adhesion in the post-ischemic guinea-pig heart. J. Physiol. Pharmacol. 56, 163-178 (Pubitemid 40911085)
78. Nieuwdorp, M., van Haeften, T.W., Gouverneur, M., Mooij, H.L., van Lieshout, M.H.P., Levi, M., Meijers, J.C.M., Holleman, F., Hoekstra, J.B.L., Vink, H. et al. (2006) Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 55, 480-486 (Pubitemid 43343279)